Microbiome segment

MCRB

Seres Therapeutics, Inc. - Common Stock

100.72% 100.72% 0

+ Medicine, Microbiome, Biotechnology

+ My List

We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.